Home » Authors » James Etheridge

Articles by James Etheridge

Pierre Fabre Seeks EMEA Nod for Milnacipran in Fibromyalgia

June 18, 2008

By James Etheridge

SiRNAsense Picks Polyplus's in Vivo Delivery Platform

June 18, 2008

By James Etheridge

Transgene's TG4010 Vaccine Meets Phase IIb Trial Endpoint

June 11, 2008

By James Etheridge

Edmond de Rothschild Closes 150 Million BioDiscovery Fund

June 4, 2008

By James Etheridge

Innate Launches Preclinical Work on First Antibody in Novo Deal

June 4, 2008

By James Etheridge

BioAlliance Buys Rights to NovaDel's Ondansetron

May 28, 2008

By James Etheridge

Trophos Launches Phase II Trial of TRO19622 in Liver Disease

May 21, 2008

By James Etheridge

NicOx Antihypertensive Taken Into Phase I Trial by Merck

May 14, 2008

By James Etheridge

Polyplus-transfection Unveils New siRNA Technology

April 30, 2008

By James Etheridge

Sanofi-Aventis Stops Developing Two Genfit Drug Candidates

April 9, 2008

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 3, 2026.
ASCO 2026: A revolution in pancreatic cancer
BioWorld
At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, Revolution Medicines Inc. followed up its stellar top-line data with the details from the...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 2, 2026
EASL 2026: Emerging liver disease targets to watch
BioWorld
At the recently concluded European Association for the Study of the Liver meeting, presentations underscored how increasingly granular insights into liver...
ASCO 2026: PD-(L)1 x VEGF bispecifics fight it out
BioWorld
Multiple companies are chasing Akeso Inc. and Summit Therapeutics Inc. in the battle to potentially dethrone Keytruda (pembrolizumab, Merck & Co. Inc.) as the top...